现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
34期
3790-3792,3796
,共4页
郎永军%魏建军%刘存英%王振琴%张平%左伟慧%武惠芳%白俊博
郎永軍%魏建軍%劉存英%王振琴%張平%左偉慧%武惠芳%白俊博
랑영군%위건군%류존영%왕진금%장평%좌위혜%무혜방%백준박
不稳定型心绞痛%盐酸川芎嗪%辅酶Q10%炎症反应%免疫功能
不穩定型心絞痛%鹽痠川芎嗪%輔酶Q10%炎癥反應%免疫功能
불은정형심교통%염산천궁진%보매Q10%염증반응%면역공능
unstable angina pectoris%ligustrazine hydrochloride%coenzyme Q10%inflammatory reaction%immunologic function
目的:观察盐酸川芎嗪联合辅酶Q10对不稳定型心绞痛患者炎症反应和免疫功能的影响。方法将不稳定型心绞痛患者215例随机分为联合用药组110例和对照组105例。联合用药组在常规治疗基础上给予盐酸川芎嗪80 mg/d和辅酶Q1010 mg/d静点,对照组仅给予常规治疗。治疗2周后观察2组临床疗效,检测治疗前后炎性因子白细胞介素-2( IL-2)、肿瘤坏死因子-α( TNF-α)、超敏C反应蛋白( hs-CRP)水平,免疫球蛋白IgA、IgG、IgM及免疫细胞亚群CD3+、CD4+、CD4+/CD8+水平。结果联合用药组的有效率为89.09%,对照组为78.10%,联合用药组有效率高于对照组(P<0.05);联合用药组心电图改善率为88.18%,高于对照组的75.24%(P<0.05);2组治疗后IL-2、TNF-α、hs-CRP水平较治疗前均明显降低(P均<0.05),且联合用药组治疗后各指标水平均低于同时点对照组(P均<0.05);治疗后2组IgA、IgG、IgM、CD3+、CD4+、CD4+/CD8+水平均明显降低;与对照组比较,除CD4+/CD8+外,各指标水平联合用药组降低更为明显( P均<0.05)。结论盐酸川芎嗪联合辅酶Q10用于治疗不稳定型心绞痛效果良好,具有抑制全身炎症反应、改善免疫功能的作用。
目的:觀察鹽痠川芎嗪聯閤輔酶Q10對不穩定型心絞痛患者炎癥反應和免疫功能的影響。方法將不穩定型心絞痛患者215例隨機分為聯閤用藥組110例和對照組105例。聯閤用藥組在常規治療基礎上給予鹽痠川芎嗪80 mg/d和輔酶Q1010 mg/d靜點,對照組僅給予常規治療。治療2週後觀察2組臨床療效,檢測治療前後炎性因子白細胞介素-2( IL-2)、腫瘤壞死因子-α( TNF-α)、超敏C反應蛋白( hs-CRP)水平,免疫毬蛋白IgA、IgG、IgM及免疫細胞亞群CD3+、CD4+、CD4+/CD8+水平。結果聯閤用藥組的有效率為89.09%,對照組為78.10%,聯閤用藥組有效率高于對照組(P<0.05);聯閤用藥組心電圖改善率為88.18%,高于對照組的75.24%(P<0.05);2組治療後IL-2、TNF-α、hs-CRP水平較治療前均明顯降低(P均<0.05),且聯閤用藥組治療後各指標水平均低于同時點對照組(P均<0.05);治療後2組IgA、IgG、IgM、CD3+、CD4+、CD4+/CD8+水平均明顯降低;與對照組比較,除CD4+/CD8+外,各指標水平聯閤用藥組降低更為明顯( P均<0.05)。結論鹽痠川芎嗪聯閤輔酶Q10用于治療不穩定型心絞痛效果良好,具有抑製全身炎癥反應、改善免疫功能的作用。
목적:관찰염산천궁진연합보매Q10대불은정형심교통환자염증반응화면역공능적영향。방법장불은정형심교통환자215례수궤분위연합용약조110례화대조조105례。연합용약조재상규치료기출상급여염산천궁진80 mg/d화보매Q1010 mg/d정점,대조조부급여상규치료。치료2주후관찰2조림상료효,검측치료전후염성인자백세포개소-2( IL-2)、종류배사인자-α( TNF-α)、초민C반응단백( hs-CRP)수평,면역구단백IgA、IgG、IgM급면역세포아군CD3+、CD4+、CD4+/CD8+수평。결과연합용약조적유효솔위89.09%,대조조위78.10%,연합용약조유효솔고우대조조(P<0.05);연합용약조심전도개선솔위88.18%,고우대조조적75.24%(P<0.05);2조치료후IL-2、TNF-α、hs-CRP수평교치료전균명현강저(P균<0.05),차연합용약조치료후각지표수평균저우동시점대조조(P균<0.05);치료후2조IgA、IgG、IgM、CD3+、CD4+、CD4+/CD8+수평균명현강저;여대조조비교,제CD4+/CD8+외,각지표수평연합용약조강저경위명현( P균<0.05)。결론염산천궁진연합보매Q10용우치료불은정형심교통효과량호,구유억제전신염증반응、개선면역공능적작용。
Objective It is to observe the effect of Ligustrazine Hydrochloride combined with Coenzyme Q10 on inflammato-ry reaction and immunologic function in patients with unstable angina pectoris.Methods 215 subjects with unstable angina pectoris were randomly divided into 2 groups:combination group (n=110) and control group (n=105).Combination group was treated with ligustrazine hydrochloride(80 mg/d) combined with coenzyme Q10 (10 mg/d) by intravenous infusion and conventional therapy, and the control group was treated with conventional treatment only.After two weeks'treatment, the clini-cal curative effect in both groups were observed and the levels of inflammatory factors, such as IL-2 , TNF-α, high sensitiv-ity C-reactive protein( hs-CRP) and levels of IgA, IgG, IgM, lymphocyte subsets CD3 +, CD4 +, CD4 +/CD8 +in periph-eral blood were all determined.Results The effective rate was 89.09% in combination group, which was higher than that of 78.10%in control group(all P<0.05); the improving rate of ECG in combination group was 88.18%, which was higher than that of 75.24%in control group(P<0.05).After treatment, the levels of IL-2, TNF-α, hs-CRP were all increased compared with pretreatment, and all indexes showed more obvious changes in combination group than that in control group( P<0.05).The levels of IgA, IgG, IgM, CD3 +, CD4 +, in both groups decreased significantly, and the levels of these inde-xes changed more significantly in combination group (P<0.05), whereas there was no significance about CD4 +/CD8 +be-tween the two groups(P>0.05).Conclusion Ligustrazine hydrochloride combined with coenzyme Q10 has a good curative effect on unstable angina pectoris, which can relieve inflammatory reaction and improve immunologic functions.